Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD -- Asia-Pacific Partner’s New Drug ...

U.S. corporate profits rebounded sharply in the fourth quarter, but an uncertain economic outlook due to tariffs is creating ...

Our strong fourth quarter performance reflects our continued progress in establishing Focal One Robotic HIFU as a mainstream treatment option for the management of prostate cancer,” said Ryan Rhodes, ...